Tagdulang, Christine F.

HRN: 22 23 70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/30/2023
02/03/2023
ORAL
500 Mg
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
02/01/2023
CEFTRIAXONE 1G (VIAL)
02/01/2023
02/08/2023
IV
2g
OD
CAP MR; Lupus Nephritis
Waiting Final Action 
03/06/2023
CEFTRIAXONE 1G (VIAL)
03/06/2023
03/13/2023
IV
1g
Q12
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: